Stockreport

NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue

Neuropace, Inc.  (NPCE) 
PDF MOUNTAIN VIEW, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) --  NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives o [Read more]